Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review (Q33261939)

24 July 2017

1 reference

title

Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review (English)

1 reference

24 July 2017

1 reference

1 reference

Kok-Yuen Ho

1

1 reference

PubMed ID

17071119

24 July 2017

Kian-Hian Tan

series ordinal

2

1 reference

24 July 2017

27 October 2006

1 reference

24 July 2017

European Journal of Pain

1 reference

24 July 2017

11

1 reference

24 July 2017

5

1 reference

24 July 2017

519-527

1 reference

Focused review: myofascial pain

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

The pharmacologic treatment of muscle pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Needling therapies in the management of myofascial trigger point pain: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Use of botulinum toxin in the treatment of chronic myofascial pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

BOTOX and physical therapy in the treatment of piriformis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Botulinum toxin A and chronic low back pain: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

A control, double-blind comparison of mepivacaine injection versus saline injection for myofascial pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Effect of botulinum toxin on endplate noise in myofascial trigger spots of rabbit skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Focused review: Botulinum toxin type A therapy in chronic pain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Structure and function of tetanus and botulinum neurotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Botulinum toxin therapy in pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Consensus statement: botulinum toxin in myofascial [corrected] pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Pharmacology of botulinum toxin: differences between type A preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Botulinum toxin type A for the treatment of chronic neck pain after neck dissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

Treatment of Chronic Low Back Pain With Successive Injections of Botulinum Toxin A Over 6 Months

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2006.09.002

10.1016/J.EJPAIN.2006.09.002

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference

PubMed ID

17071119